(Q71548810)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8814305%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

title

Structural comparison of a 15 residue peptide from the V3 loop of HIV-1IIIb and an O-glycosylated analogue (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8814305%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

author name string

X Huang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8814305%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

M C Smith

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8814305%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

J A Berzofsky

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8814305%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

J J Barchi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8814305%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

language of work or name

English

0 references

publication date

1 September 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8814305%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8814305%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

volume

393

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8814305%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

issue

2-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8814305%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

page(s)

280-286

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8814305%20AND%20SRC:MED&resulttype=core&format=json

Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein

19 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2896%2900912-X

Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2896%2900912-X

Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2896%2900912-X

Broadly Neutralizing Monoclonal Antibodies to the V3 Region of HIV-1 Can Be Elicited by Peptide Immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2896%2900912-X

Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Ev

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2896%2900912-X

21 January 2018

AIDS and glycosylation

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2896%2900912-X

Functions of HIV envelope glycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2896%2900912-X

Interaction between the human T-cell lymphotropic virus type IIIB envelope glycoprotein gp120 and the surface antigen CD4: role of carbohydrate in binding and cell fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2896%2900912-X

Attenuation of HIV-1 infectivity by an inhibitor of oligosaccharide processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2896%2900912-X

Effect of a Glucosidase Inhibitor On The Bioactivity And Immunoreactivity of hUman Immunodeficiency Virus Type 1 Envelope Glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2896%2900912-X

21 January 2018

Anti-HIV drug mechanism

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2896%2900912-X

Solution structure of the V3 loop of a Thailand HIV isolate

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2896%2900912-X

Human immunodeficiency virus (HIV) antigens: structure and serology of multivalent human mucin MUC1-HIV V3 chimeric proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2896%2900912-X

An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2896%2900912-X

Structural requirements for class I MHC molecule-mediated antigen presentation and cytotoxic T cell recognition of an immunodominant determinant of the human immunodeficiency virus envelope protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2896%2900912-X

A single amino acid interchange yields reciprocal CTL specificities for HIV-1 gp160

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2896%2900912-X

Induction of broadly cross-reactive cytotoxic T cells recognizing an HIV-1 envelope determinant

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2896%2900912-X

Synthesis of mono- and disaccharide amino-acid derivatives for use in solid phase peptide synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2896%2900912-X

CHARMM: A program for macromolecular energy, minimization, and dynamics calculations

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2896%2900912-X

Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2896%2900912-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2896%2900912-X

Solution conformational preferences of immunogenic peptides derived from the principal neutralizing determinant of the HIV-1 envelope glycoprotein gp120.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2896%2900912-X

The principal neutralizing determinant of HIV-1 located in V3 of gp120 forms a 12-residue loop by internal hydrophobic interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2896%2900912-X

NMR-derived solution conformations of a hybrid synthetic peptide containing multiple epitopes of envelope protein gp120 from the RF strain of human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2896%2900912-X

Crystal structure of a human immunodeficiency virus type 1 neutralizing antibody, 50.1, in complex with its V3 loop peptide antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2896%2900912-X

Conformational implications of asparagine-linked glycosylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2896%2900912-X

Chemical glycosylation of peptide T at natural and artificial glycosylation sites stabilizes or rearranges the dominant reverse turn structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2896%2900912-X

Effects of glycosylation on the conformation and dynamics of O-linked glycoproteins: carbon-13 NMR studies of ovine submaxillary mucin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2896%2900912-X

Secondary structural elements as a basis for antibody recognition in the immunodominant region of human immunodeficiency viruses 1 and 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2896%2900912-X

Serum angiotensin-1 converting enzyme activity processes a human immunodeficiency virus 1 gp160 peptide for presentation by major histocompatibility complex class I molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2896%2900912-X

10.1016/0014-5793(96)00912-X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8814305%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

1 reference